Kate H. Brettingham‐Moore

854 total citations
19 papers, 674 citations indexed

About

Kate H. Brettingham‐Moore is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Kate H. Brettingham‐Moore has authored 19 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Immunology. Recurrent topics in Kate H. Brettingham‐Moore's work include Acute Myeloid Leukemia Research (3 papers), Epigenetics and DNA Methylation (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Kate H. Brettingham‐Moore is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Epigenetics and DNA Methylation (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Kate H. Brettingham‐Moore collaborates with scholars based in Australia, United Kingdom and South Korea. Kate H. Brettingham‐Moore's co-authors include Emma L. Northrop, Lee H. Wong, K. H. Andy Choo, Anderly C. Chüeh, Margaret Shaw, Richard Saffery, Ross D. Hannan, Julie Quach, Melissa A. Anderson and E. J. Williams and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Oncogene.

In The Last Decade

Kate H. Brettingham‐Moore

19 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kate H. Brettingham‐Moore Australia 13 491 266 115 83 75 19 674
Ángel Martínez‐Ramírez Spain 17 564 1.1× 174 0.7× 122 1.1× 153 1.8× 90 1.2× 26 843
Kikuë Tachibana Germany 15 1000 2.0× 200 0.8× 178 1.5× 108 1.3× 180 2.4× 23 1.2k
Caroline Braem Belgium 8 678 1.4× 110 0.4× 99 0.9× 156 1.9× 38 0.5× 10 928
Ofer Shoshani United States 11 679 1.4× 173 0.7× 115 1.0× 318 3.8× 230 3.1× 16 895
Celia R. Espinoza United States 13 396 0.8× 112 0.4× 44 0.4× 49 0.6× 24 0.3× 22 649
Yoko Hosoya Japan 15 479 1.0× 53 0.2× 165 1.4× 124 1.5× 64 0.9× 21 666
Mirjam S. de Pagter Netherlands 6 331 0.7× 88 0.3× 126 1.1× 187 2.3× 172 2.3× 7 557
Kinnimulki Vijayachandra United States 10 369 0.8× 85 0.3× 95 0.8× 52 0.6× 35 0.5× 10 492
Athanasios Kotsinas Greece 9 350 0.7× 47 0.2× 121 1.1× 93 1.1× 26 0.3× 15 482
Shannon Lauberth United States 11 892 1.8× 61 0.2× 105 0.9× 231 2.8× 48 0.6× 17 1.1k

Countries citing papers authored by Kate H. Brettingham‐Moore

Since Specialization
Citations

This map shows the geographic impact of Kate H. Brettingham‐Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate H. Brettingham‐Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate H. Brettingham‐Moore more than expected).

Fields of papers citing papers by Kate H. Brettingham‐Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate H. Brettingham‐Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate H. Brettingham‐Moore. The network helps show where Kate H. Brettingham‐Moore may publish in the future.

Co-authorship network of co-authors of Kate H. Brettingham‐Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Kate H. Brettingham‐Moore. A scholar is included among the top collaborators of Kate H. Brettingham‐Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate H. Brettingham‐Moore. Kate H. Brettingham‐Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wilson, Richard, E. J. Wilkinson, Joanne L. Dickinson, et al.. (2023). Multiomics analysis of adaptation to repeated DNA damage in prostate cancer cells. Epigenetics. 18(1). 2214047–2214047. 2 indexed citations
2.
Giles, Katherine A., et al.. (2023). The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target. Oncogene. 42(31). 2363–2373. 26 indexed citations
3.
Taberlay, Phillippa C., Adele F. Holloway, Mark Ambrose, et al.. (2019). DNA methylation changes following DNA damage in prostate cancer cells. Epigenetics. 14(10). 989–1002. 19 indexed citations
4.
Taberlay, Phillippa C., et al.. (2017). Distinct mechanisms of regulation of the ITGA6 and ITGB4 genes by RUNX1 in myeloid cells. Journal of Cellular Physiology. 233(4). 3439–3453. 13 indexed citations
5.
Taberlay, Phillippa C., Arabella Young, Alison C. West, et al.. (2015). The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1. Journal of Cellular Biochemistry. 117(1). 49–58. 9 indexed citations
6.
Patchett, Amanda L., R Latham, Kate H. Brettingham‐Moore, et al.. (2015). Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil. Developmental & Comparative Immunology. 53(1). 123–133. 16 indexed citations
7.
Brettingham‐Moore, Kate H., Phillippa C. Taberlay, & Adele F. Holloway. (2015). Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia. Frontiers in Immunology. 6. 499–499. 24 indexed citations
8.
Young, Arabella, Adele F. Holloway, Nicholas B. Blackburn, et al.. (2014). RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization. BMC Cancer. 14(1). 808–808. 31 indexed citations
9.
Thắng, Trần Nam, Kate H. Brettingham‐Moore, Cuong Duong, et al.. (2013). Molecular changes in the phosphatidylinositide 3‐kinase (PI3K) pathway are common in gastric cancer. Journal of Surgical Oncology. 108(2). 113–120. 12 indexed citations
10.
11.
Brettingham‐Moore, Kate H., Cuong Duong, Danielle Greenawalt, et al.. (2011). Pretreatment Transcriptional Profiling for Predicting Response to Neoadjuvant Chemoradiotherapy in Rectal Adenocarcinoma. Clinical Cancer Research. 17(9). 3039–3047. 43 indexed citations
12.
Pilgrim, Charles, Kate H. Brettingham‐Moore, Alan Pham, et al.. (2011). mRNA gene expression correlates with histologically diagnosed chemotherapy-induced hepatic injury. HPB. 13(11). 811–816. 10 indexed citations
13.
Brettingham‐Moore, Kate H., Cuong Duong, Alexander G. Heriot, Robert J. S. Thomas, & Wayne A. Phillips. (2010). Using Gene Expression Profiling to Predict Response and Prognosis in Gastrointestinal Cancers—The Promise and the Perils. Annals of Surgical Oncology. 18(5). 1484–1491. 24 indexed citations
14.
Chüeh, Anderly C., Emma L. Northrop, Kate H. Brettingham‐Moore, K. H. Andy Choo, & Lee H. Wong. (2009). LINE Retrotransposon RNA Is an Essential Structural and Functional Epigenetic Component of a Core Neocentromeric Chromatin. PLoS Genetics. 5(1). e1000354–e1000354. 133 indexed citations
15.
Chüeh, Anderly C., Emma L. Northrop, Kate H. Brettingham‐Moore, K.H. Andy Choo, & Lee H. Wong. (2009). Correction: LINE Retrotransposon RNA Is an Essential Structural and Functional Epigenetic Component of a Core Neocentromeric Chromatin. PLoS Genetics. 5(2). 22 indexed citations
16.
Brettingham‐Moore, Kate H., et al.. (2008). Determinants of a transcriptionally competent environment at the GM-CSF promoter. Nucleic Acids Research. 36(8). 2639–2653. 15 indexed citations
17.
Wong, Lee H., Kate H. Brettingham‐Moore, Julie Quach, et al.. (2007). Centromere RNA is a key component for the assembly of nucleoproteins at the nucleolus and centromere. Genome Research. 17(8). 1146–1160. 235 indexed citations
18.
Chen, Xinxin, et al.. (2006). Chromatin Remodelling: Distinct Molecular Events During Differentiation and Activation of T Cells. Current Immunology Reviews. 2(3). 273–289. 1 indexed citations
19.
Brettingham‐Moore, Kate H.. (2005). GM-CSF promoter chromatin remodelling and gene transcription display distinct signal and transcription factor requirements. Nucleic Acids Research. 33(1). 225–234. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ángel Martínez‐Ramírez Breakdown of academic impact, for papers by Kikuë Tachibana Breakdown of academic impact, for papers by Caroline Braem Breakdown of academic impact, for papers by Ofer Shoshani Breakdown of academic impact, for papers by Celia R. Espinoza Breakdown of academic impact, for papers by Yoko Hosoya Breakdown of academic impact, for papers by Mirjam S. de Pagter Breakdown of academic impact, for papers by Kinnimulki Vijayachandra Breakdown of academic impact, for papers by Athanasios Kotsinas Breakdown of academic impact, for papers by Shannon Lauberth
Rankless by CCL
2026